DexCom, Inc.
DXCM
$61.14
$1.813.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 89.28% | 76.20% | 110.85% | 25.30% | -28.01% |
| Total Depreciation and Amortization | 11.83% | 9.93% | 15.01% | 20.92% | 14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.78% | 39.24% | 1,404.84% | 133.33% | 306.90% |
| Change in Net Operating Assets | 53,500.00% | -2,459.38% | 1,365.82% | -66.86% | -97.89% |
| Cash from Operations | 185.96% | -2.46% | 230.78% | 8.45% | -12.14% |
| Capital Expenditure | 11.95% | 18.22% | 27.61% | -42.36% | -52.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -218.54% | 328.08% | -14.99% | 124.84% | 42.14% |
| Cash from Investing | -397.90% | 200.95% | -8.32% | 66.33% | 33.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -10.56% | -- | -6.08% | -- | 5.97% |
| Repurchase of Common Stock | -- | -- | 75.04% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.76% | -18.75% | -30.77% | -21.43% | 80.46% |
| Cash from Financing | -300.00% | -95,037.50% | 76.24% | -21.43% | 165.96% |
| Foreign Exchange rate Adjustments | -221.74% | 133.93% | -112.79% | 1,750.00% | 160.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.30% | -5,978.15% | 312.70% | 188.54% | 4.88% |